Clinical trial
Pioglitazone in Hepatitis C
NCT00189163 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00189163 |
|---|---|
| Title | Pioglitazone in Hepatitis C |
| Official title | Pioglitazone in Hepatitis C: A Randomized, Double Blind, Placebo-controlled Study |
| Lead sponsor | University of Michigan, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Pioglitazone, Placebo Oral Tablet |
| Enrollment | 40 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 16, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: